Healthcare - Sector Analysis and Overview
Find out the best companies in the Industry/ Sector/ Index of your choice, based on critical criteria.
| # |
 
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Dr. Reddys Labs. | Pharmaceuticals& Drugs | 1,140.8 |
-2.4 (-0.21%) |
Mid Cap | 33,700 | 38.6 | 11.44 | 29.6 | 2.5 | |
| Lupin | Pharmaceuticals& Drugs | 2,075 |
-17 (-0.81%) |
Mid Cap | 27,958 | 120.9 | 18.82 | 17.3 | 4 | |
| Zydus Lifesciences | Pharmaceuticals& Drugs | 1,118 |
-11 (-0.97%) |
Mid Cap | 27,148 | 45.2 | 16.54 | 25 | 4.2 | |
| Glenmark Pharma. | Pharmaceuticals& Drugs | 2,417 |
-22.55 (-0.92%) |
Mid Cap | 16,983 | 63.7 | 15.9 | 38.3 | 6.3 | |
| Aurobindo Pharma | Pharmaceuticals& Drugs | 1,669 |
-21 (-1.24%) |
Mid Cap | 11,172 | 45.1 | 20.59 | 37.5 | 4.2 | |
| Mankind Pharma | Pharmaceuticals& Drugs | 2,246 |
-20 (-0.88%) |
Mid Cap | 10,421 | 52.8 | 19.97 | 42.9 | 5.5 | |
| Alkem Laboratories | Pharmaceuticals& Drugs | 5,110.2 |
-29.8 (-0.58%) |
Mid Cap | 9,664 | 178.4 | 22.7 | 28.8 | 4.2 | |
| Max Healthcare Inst. | Hospital &HealthcareServices | 1,039 |
2.5 (0.24%) |
Mid Cap | 8,373 | 15 | 17.65 | 69.2 | 9.2 | |
| Narayana Hrudayalay. | Hospital &HealthcareServices | 1,909.1 |
20.3 (1.07%) |
Mid Cap | 7,896 | 39.9 | 10.69 | 47.3 | 8.1 | |
| Ipca Laboratories | Pharmaceuticals& Drugs | 1,970.1 |
6.4 (0.33%) |
Mid Cap | 7,289 | 49 | 16.38 | 40.1 | 6 | |
| Abbott India | Pharmaceuticals& Drugs | 25,272.6 |
49.2 (0.2%) |
Mid Cap | 6,929 | 759.9 | 22.25 | 33.2 | 10.4 | |
| Laurus Labs | Pharmaceuticals& Drugs | 1,936 |
2.75 (0.14%) |
Mid Cap | 6,813 | 20.2 | 12.82 | 95.5 | 18.5 | |
| Ajanta Pharma | Pharmaceuticals& Drugs | 3,516.8 |
-22.5 (-0.64%) |
Mid Cap | 5,453 | 90.8 | 19.33 | 39 | 9.1 | |
| Lenskart Solutions | MedicalEquipment/Supplies/Accessories | 693.2 |
-0.85 (-0.12%) |
Mid Cap | 5,248 | 3 | 9.36 | 230.9 | 13.1 | |
| Aster DM Quality | Hospital &HealthcareServices | 766.7 |
-13.35 (-1.71%) |
Mid Cap | 4,138 | 3.7 | 8.01 | 213.4 | 13.7 | |
| Glaxosmithkline Phar | Pharmaceuticals& Drugs | 2,840.8 |
-45.35 (-1.57%) |
Mid Cap | 3,822 | 63.1 | 25.36 | 45.8 | 19.4 | |
| Manipal Health Enter | Hospital &HealthcareServices | 733.1 |
3.15 (0.43%) |
Mid Cap | 3,104 | 4.1 | 17.18 | 179.4 | 6.4 | |
| Biocon | Pharmaceuticals& Drugs | 390 |
-5 (-1.27%) |
Mid Cap | 2,346 | 0.6 | 5.85 | 658.9 | 2.4 | |
| Anthem Biosciences | Pharmaceuticals& Drugs | 941.7 |
-1.9 (-0.2%) |
Mid Cap | 2,089 | 11.1 | 30.95 | 85.2 | 16.3 | |
| Fortis Healthcare | Hospital &HealthcareServices | 901.8 |
-10.1 (-1.11%) |
Mid Cap | 1,792 | 3 | 11.65 | 304.3 | 7.4 |
Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now. Subscribe to Sapphire
About MoneyWorks4Me
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
Our Vision
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
What Makes MoneyWorks4Me Different
-
Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free. -
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach. -
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding. -
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best. -
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.
Our Approach: Ensuring compounding work its magic on client portfolio.
MoneyWorks4Me ensures this through:
- Investing in stocks, mutual funds, debt, and gold
- Quality-at-Reasonable-Price way of investing in stocks
- Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
- A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
- Periodic review and rebalancing
- Clear Buy-Sell-Hold, and Position-sizing frameworks
MoneyWorks4Me method for rating and ranking mutual funds for SIP
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
- Performance Consistency: This is measure based on whether the fund has beaten the benchmark index consistently. For this we compare the 3-year rolling returns of the fund with the benchmark for a minimum of 5 years and preferable 10 years. The period of rolling is one month and holding period is 3 years. Fund are color-coded Green on Performance when the fund beats the benchmark more than 90% of the time. It is Orange if it beats 80% to 90% of the time and Red if less than 80%. Funds with less than 5 year data are color-coded Grey.
- Quality of Portfolio Holding: Moneyworks4Me has color-coded stocks as Green, Orange and Red based on whether the company's performance has generated a ROCE above a threshold level (cost of capital) over 10 years (minimum 6 years) and generated positive Free Cash Flow. For Banks it checks whether ROE is greater than 15% and sales has grown over previous year. Stocks that perform consistently on these combined metrics are color-coded Green (min score 14 out of 20), Orange (between 8 and 14) and Red (less than 8 out of 20). Fund are color-coded Green provided the portfolio has 70% holding in Green stocks but not more than 20% in Red stocks. Funds with more than 20% Red stocks in the portfolio are color-coded Red. The rest are Orange funds
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Q Very Good
Q Somewhat Good
Q Not Good
V+UnderValued (UV)
V Somewhat UV
V Fair Value
V Somewhat OV
V+ OverValued (OV)
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
SEBI Registered Investment Adviser
|
Name of the IA registered
with SEBI: |
The Alchemists Ark Pvt. Ltd. |
|
Logo:
|
|
|
Trade/Brand
Name of IA: |
MoneyWorks4Me Investment Advisers |
|
Brand Logo:
|
 |
|
SEBI Registration Number:
|
INA000013323 Validity – May 16, 2019 – Perpetual |
|
Registration:
|
Non-Individual |
|
BSE Enlistment No:
|
1187 |
|
Address:
|
B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045 |
|
Compliance Officer
Details: |
Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com |
Telephone: +919860359463 Address: Same as IA |
|
Grievance Officer
Details: |
Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com |
Telephone: +919860919463 Address: Same as IA |
|
Principal Officer
Details: |
Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com |
Telephone: +919175899463 Address: Same as IA |
|
Standard Warning:
|
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. |
|
|
Disclaimer:
|
Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. |
|